Difference between revisions of "LncRNAWiki:C"

From LncRNAWiki
Jump to: navigation, search
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''C1QTNF9B-AS1'' |C1QTNF9B-AS1 |PCOTH |C1QTNF9B antisense ...")
 
Line 1: Line 1:
 +
 +
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 +
Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] '''C''' [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''Featured''']]
 +
</div>
 +
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
Line 5: Line 10:
 
!Alias
 
!Alias
 
!Description
 
!Description
 +
!Disease
 
|-
 
|-
 
|''C1QTNF9B-AS1''
 
|''C1QTNF9B-AS1''
Line 10: Line 16:
 
|PCOTH
 
|PCOTH
 
|C1QTNF9B antisense RNA 1
 
|C1QTNF9B antisense RNA 1
 +
|prostate cancer
 
|-
 
|-
 
|''C21orf91-OT1''
 
|''C21orf91-OT1''
Line 15: Line 22:
 
|D21S2089E
 
|D21S2089E
 
|C21orf91 overlapping transcript 1
 
|C21orf91 overlapping transcript 1
 +
|_
 
|-
 
|-
 
|''C5orf66-AS1''
 
|''C5orf66-AS1''
 
|[[C5orf66-AS1]]
 
|[[C5orf66-AS1]]
−
|CTC-276P9.1, Epist
+
|"CTC-276P9.1, Epist"
 
|C5orf66 antisense RNA 1
 
|C5orf66 antisense RNA 1
 +
|esophageal squamous cell carcinoma
 
|-
 
|-
 
|''C5orf66-AS2''
 
|''C5orf66-AS2''
Line 25: Line 34:
 
|N/A
 
|N/A
 
|C5orf66 antisense RNA 2
 
|C5orf66 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''C8orf34-AS1''
 
|''C8orf34-AS1''
Line 30: Line 40:
 
|N/A
 
|N/A
 
|C8orf34 antisense RNA 1
 
|C8orf34 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CACNA1G-AS1''
 
|''CACNA1G-AS1''
Line 35: Line 46:
 
|N/A
 
|N/A
 
|CACNA1G antisense RNA 1
 
|CACNA1G antisense RNA 1
 +
|keloid
 
|-
 
|-
 
|''CAHM''
 
|''CAHM''
Line 40: Line 52:
 
|LINC00468
 
|LINC00468
 
|colon adenocarcinoma hypermethylated (non-protein coding)
 
|colon adenocarcinoma hypermethylated (non-protein coding)
 +
|colorectal neoplasia.
 
|-
 
|-
 
|''CAPN10-AS1''
 
|''CAPN10-AS1''
Line 45: Line 58:
 
|locus959
 
|locus959
 
|CAPN10 antisense RNA 1 (head to head)
 
|CAPN10 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CAR Intergenic 10''
 
|''CAR Intergenic 10''
 
|[[NONHSAT016928]],[[lnc-FANK1-3:1]]
 
|[[NONHSAT016928]],[[lnc-FANK1-3:1]]
−
|Intergenic10, CR611911, AK055628
+
|"Intergenic10, CR611911, AK055628"
 
|Chromatin Associated RNA 10
 
|Chromatin Associated RNA 10
 +
|_
 
|-
 
|-
 
|''CARD8-AS1''
 
|''CARD8-AS1''
Line 55: Line 70:
 
|LOC100505812
 
|LOC100505812
 
|CARD8 antisense RNA 1
 
|CARD8 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CARMN''
 
|''CARMN''
Line 60: Line 76:
 
|CARMEN
 
|CARMEN
 
|cardiac mesoderm enhancer-associated non-coding RNA
 
|cardiac mesoderm enhancer-associated non-coding RNA
 +
|_
 
|-
 
|-
 
|''CASC11''
 
|''CASC11''
 
|[[CASC11]]
 
|[[CASC11]]
−
|TCONSN/A00014535, LINC00990, CARLo-7
+
|"TCONSN/A00014535, LINC00990, CARLo-7"
 
|cancer susceptibility candidate 11 (non-protein coding)
 
|cancer susceptibility candidate 11 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CASC15''
 
|''CASC15''
Line 70: Line 88:
 
|N/A
 
|N/A
 
|cancer susceptibility candidate 15 (non-protein coding)
 
|cancer susceptibility candidate 15 (non-protein coding)
 +
|metastatic melanoma
 
|-
 
|-
 
|''CASC19''
 
|''CASC19''
Line 75: Line 94:
 
|CARLo-6
 
|CARLo-6
 
|cancer susceptibility candidate 19 (non-protein coding)
 
|cancer susceptibility candidate 19 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''CASC2''
 
|''CASC2''
Line 80: Line 100:
 
|N/A
 
|N/A
 
|cancer susceptibility candidate 2 (non-protein coding)
 
|cancer susceptibility candidate 2 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CASC21''
 
|''CASC21''
Line 85: Line 106:
 
|CARLo-2
 
|CARLo-2
 
|cancer susceptibility candidate 21 (non-protein coding)
 
|cancer susceptibility candidate 21 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CASC22''
 
|''CASC22''
 
|[[CASC22]]
 
|[[CASC22]]
−
|TCONSN/A00024290, LincRNA-ENST00000515084
+
|"TCONSN/A00024290, LincRNA-ENST00000515084"
 
|cancer susceptibility candidate 22 (non-protein coding)
 
|cancer susceptibility candidate 22 (non-protein coding)
 +
|breast cancer
 
|-
 
|-
 
|''CASC8''
 
|''CASC8''
 
|[[CASC8]]
 
|[[CASC8]]
−
|LINC00860,CARLo-1
+
|"LINC00860,CARLo-1"
 
|cancer susceptibility candidate 8 (non-protein coding)
 
|cancer susceptibility candidate 8 (non-protein coding)
 +
|Colorectal Cancer,Lung Cancer
 
|-
 
|-
 
|''CASC9''
 
|''CASC9''
 
|[[CASC9]]
 
|[[CASC9]]
−
|LINC00981, ESCCAL-1
+
|"LINC00981, ESCCAL-1"
 
|cancer susceptibility candidate 9 (non-protein coding)
 
|cancer susceptibility candidate 9 (non-protein coding)
 +
|predicted esophageal squamous cell carcinoma
 
|-
 
|-
 
|''CBR3-AS1''
 
|''CBR3-AS1''
Line 105: Line 130:
 
|PlncRNA-1
 
|PlncRNA-1
 
|CBR3 antisense RNA 1
 
|CBR3 antisense RNA 1
 +
|esophageal squamous carcinoma cell
 
|-
 
|-
 
|''CCAT1''
 
|''CCAT1''
 
|[[NONHSAT129017]]
 
|[[NONHSAT129017]]
−
|CARLo-5, onco-lncRNA-40
+
|"CARLo-5, onco-lncRNA-40"
 
|colon cancer associated transcript 1 (non-protein coding)
 
|colon cancer associated transcript 1 (non-protein coding)
 +
|colorectal cancer,gastric cancer
 
|-
 
|-
 
|''CCAT2''
 
|''CCAT2''
 
|[[CCAT2]]
 
|[[CCAT2]]
−
|NCCP1, LINC00873
+
|"NCCP1, LINC00873"
 
|colon cancer associated transcript 2 (non-protein coding)
 
|colon cancer associated transcript 2 (non-protein coding)
 +
|non-small cell lung cancer
 
|-
 
|-
 
|''CCDC18-AS1''
 
|''CCDC18-AS1''
Line 120: Line 148:
 
|ENST00000440778.1
 
|ENST00000440778.1
 
|CCDC18 antisense RNA 1
 
|CCDC18 antisense RNA 1
 +
|Adolescent Idiopathic Scoliosis
 
|-
 
|-
 
|''CCDC26''
 
|''CCDC26''
 
|[[CCDC26]]
 
|[[CCDC26]]
−
|MGC27434, RAM
+
|"MGC27434, RAM"
 
|CCDC26 long non-coding RNA
 
|CCDC26 long non-coding RNA
 +
|glioma
 
|-
 
|-
 
|''CCEPR''
 
|''CCEPR''
Line 130: Line 160:
 
|CCHE1
 
|CCHE1
 
|cervical carcinoma expressed PCNA regulatory lncRNA
 
|cervical carcinoma expressed PCNA regulatory lncRNA
 +
|cervical cancer
 
|-
 
|-
 
|''CDKN1A-AS1''
 
|''CDKN1A-AS1''
Line 135: Line 166:
 
|p21NAT
 
|p21NAT
 
|CDKN1A antisense RNA 1
 
|CDKN1A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CDKN2B-AS1''
 
|''CDKN2B-AS1''
 
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
 
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
−
|ANRIL, p15AS, ENSG00000240498
+
|"ANRIL, p15AS, ENSG00000240498"
 
|CDKN2B antisense RNA 1
 
|CDKN2B antisense RNA 1
 +
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
 
|-
 
|-
 
|''CDR1-AS''
 
|''CDR1-AS''
 
|[[CDR1-AS]]
 
|[[CDR1-AS]]
−
|CDR1NAT, ciRS-7, CDR1as
+
|"CDR1NAT, ciRS-7, CDR1as"
 
|CDR1 antisense RNA
 
|CDR1 antisense RNA
 +
|_
 
|-
 
|-
 
|''CDRT7''
 
|''CDRT7''
 
|[[CDRT7]]
 
|[[CDRT7]]
−
|NCRNA00025, LINC00025
+
|"NCRNA00025, LINC00025"
 
|CMT1A duplicated region transcript 7 (non-protein coding)
 
|CMT1A duplicated region transcript 7 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CDRT8''
 
|''CDRT8''
Line 155: Line 190:
 
|N/A
 
|N/A
 
|CMT1A duplicated region transcript 8
 
|CMT1A duplicated region transcript 8
 +
|_
 
|-
 
|-
 
|''CECR3''
 
|''CECR3''
 
|[[CECR3]]
 
|[[CECR3]]
 
|N/A
 
|N/A
−
|cat eye syndrome chromosome region, candidate 3 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR5-AS1''
 
|''CECR5-AS1''
Line 165: Line 202:
 
|NCRNA00017
 
|NCRNA00017
 
|CECR5 antisense RNA 1
 
|CECR5 antisense RNA 1
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR7''
 
|''CECR7''
 
|[[CECR7]]
 
|[[CECR7]]
 
|SAHL1
 
|SAHL1
−
|cat eye syndrome chromosome region, candidate 7 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR9''
 
|''CECR9''
 
|[[CECR9]]
 
|[[CECR9]]
 
|N/A
 
|N/A
−
|cat eye syndrome chromosome region, candidate 9 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CEP83-AS1''
 
|''CEP83-AS1''
Line 180: Line 220:
 
|N/A
 
|N/A
 
|CEP83 antisense RNA 1 (head to head)
 
|CEP83 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CIRBP-AS1''
 
|''CIRBP-AS1''
Line 185: Line 226:
 
|MGC39338
 
|MGC39338
 
|CIRBP antisense RNA 1
 
|CIRBP antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CISTR''
 
|''CISTR''
 
|[[NONHSAT028496]]
 
|[[NONHSAT028496]]
−
|CISTR-ACT, CISTRACT, re52431
+
|"CISTR-ACT, CISTRACT, re52431"
 
|chondrogenesis-associated transcript
 
|chondrogenesis-associated transcript
 +
|_
 
|-
 
|-
 
|''CLRN1-AS1''
 
|''CLRN1-AS1''
Line 195: Line 238:
 
|UCRP
 
|UCRP
 
|CLRN1 antisense RNA 1
 
|CLRN1 antisense RNA 1
 +
|Usher syndrome type 3
 
|-
 
|-
 
|''COPG2IT1''
 
|''COPG2IT1''
 
|[[COPG2IT1]]
 
|[[COPG2IT1]]
−
|CIT1, NCRNA00170, COPG2AS
+
|"CIT1, NCRNA00170, COPG2AS"
 
|COPG2 imprinted transcript 1 (non-protein coding)
 
|COPG2 imprinted transcript 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CPS1-IT1''
 
|''CPS1-IT1''
 
|[[CPS1-IT1]]
 
|[[CPS1-IT1]]
−
|PRO0132, CPS1-IT
+
|"PRO0132, CPS1-IT"
 
|CPS1 intronic transcript 1
 
|CPS1 intronic transcript 1
 +
|_
 
|-
 
|-
 
|''CRNDE''
 
|''CRNDE''
 
|[[Lnc-IRX3-4:2]]
 
|[[Lnc-IRX3-4:2]]
−
|LOC643911, LINC00180, CRNDEP
+
|"LOC643911, LINC00180, CRNDEP"
 
|colorectal neoplasia differentially expressed (non-protein coding)
 
|colorectal neoplasia differentially expressed (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CSNK1G2-AS1''
 
|''CSNK1G2-AS1''
Line 215: Line 262:
 
|MGC39696
 
|MGC39696
 
|CSNK1G2 antisense RNA 1
 
|CSNK1G2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CSTF3-AS1''
 
|''CSTF3-AS1''
Line 220: Line 268:
 
|N/A
 
|N/A
 
|CSTF3 antisense RNA 1 (head to head)
 
|CSTF3 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CTBP1-AS''
 
|''CTBP1-AS''
Line 225: Line 274:
 
|PCAT10
 
|PCAT10
 
|CTBP1 antisense RNA
 
|CTBP1 antisense RNA
 +
|prostate cancer
 
|-
 
|-
 
|''CTBP1-AS2''
 
|''CTBP1-AS2''
Line 230: Line 280:
 
|MGC21675
 
|MGC21675
 
|CTBP1 antisense RNA 2 (head to head)
 
|CTBP1 antisense RNA 2 (head to head)
 +
|_
 
|-
 
|-
 
|''CYP1B1-AS1''
 
|''CYP1B1-AS1''
Line 235: Line 286:
 
|MGC34824
 
|MGC34824
 
|CYP1B1 antisense RNA 1
 
|CYP1B1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CYP4A22-AS1''
 
|''CYP4A22-AS1''
 
|[[ENST00000444042.2]]
 
|[[ENST00000444042.2]]
−
|Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506
+
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
 
|CYP4A22 antisense RNA 1
 
|CYP4A22 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CYP51A1-AS1''
 
|''CYP51A1-AS1''
 
|[[CYP51A1-AS1]]
 
|[[CYP51A1-AS1]]
−
|ENST00000453068, LRRD1-AS1
+
|"ENST00000453068, LRRD1-AS1"
 
|CYP51A1 antisense RNA 1
 
|CYP51A1 antisense RNA 1
 +
|renal cell carcinoma
 
|-
 
|-
 
|''CYYR1-AS1''
 
|''CYYR1-AS1''
Line 250: Line 304:
 
|cysteine and tyrosine rich 1 antisense RNA 1
 
|cysteine and tyrosine rich 1 antisense RNA 1
 
|N/A
 
|N/A
 +
|_
 
|}
 
|}

Revision as of 10:01, 30 June 2016

Jump to section in alphabetical order : A B C D E F G H I J K L M N O P R S T U V W X Y Z Featured

Name Transcript ID Alias Description Disease
C1QTNF9B-AS1 C1QTNF9B-AS1 PCOTH C1QTNF9B antisense RNA 1 prostate cancer
C21orf91-OT1 C21orf91-OT1 D21S2089E C21orf91 overlapping transcript 1 _
C5orf66-AS1 C5orf66-AS1 "CTC-276P9.1, Epist" C5orf66 antisense RNA 1 esophageal squamous cell carcinoma
C5orf66-AS2 C5orf66-AS2 N/A C5orf66 antisense RNA 2 _
C8orf34-AS1 C8orf34-AS1 N/A C8orf34 antisense RNA 1 _
CACNA1G-AS1 CACNA1G-AS1 N/A CACNA1G antisense RNA 1 keloid
CAHM ENST00000604200.1 LINC00468 colon adenocarcinoma hypermethylated (non-protein coding) colorectal neoplasia.
CAPN10-AS1 CAPN10-AS1 locus959 CAPN10 antisense RNA 1 (head to head) _
CAR Intergenic 10 NONHSAT016928,lnc-FANK1-3:1 "Intergenic10, CR611911, AK055628" Chromatin Associated RNA 10 _
CARD8-AS1 CARD8-AS1 LOC100505812 CARD8 antisense RNA 1 _
CARMN CARMN CARMEN cardiac mesoderm enhancer-associated non-coding RNA _
CASC11 CASC11 "TCONSN/A00014535, LINC00990, CARLo-7" cancer susceptibility candidate 11 (non-protein coding) colorectal cancer
CASC15 CASC15 N/A cancer susceptibility candidate 15 (non-protein coding) metastatic melanoma
CASC19 CASC19 CARLo-6 cancer susceptibility candidate 19 (non-protein coding) prostate cancer
CASC2 CASC2 N/A cancer susceptibility candidate 2 (non-protein coding) colorectal cancer
CASC21 CASC21 CARLo-2 cancer susceptibility candidate 21 (non-protein coding) _
CASC22 CASC22 "TCONSN/A00024290, LincRNA-ENST00000515084" cancer susceptibility candidate 22 (non-protein coding) breast cancer
CASC8 CASC8 "LINC00860,CARLo-1" cancer susceptibility candidate 8 (non-protein coding) Colorectal Cancer,Lung Cancer
CASC9 CASC9 "LINC00981, ESCCAL-1" cancer susceptibility candidate 9 (non-protein coding) predicted esophageal squamous cell carcinoma
CBR3-AS1 CBR3-AS1 PlncRNA-1 CBR3 antisense RNA 1 esophageal squamous carcinoma cell
CCAT1 NONHSAT129017 "CARLo-5, onco-lncRNA-40" colon cancer associated transcript 1 (non-protein coding) colorectal cancer,gastric cancer
CCAT2 CCAT2 "NCCP1, LINC00873" colon cancer associated transcript 2 (non-protein coding) non-small cell lung cancer
CCDC18-AS1 CCDC18-AS1 ENST00000440778.1 CCDC18 antisense RNA 1 Adolescent Idiopathic Scoliosis
CCDC26 CCDC26 "MGC27434, RAM" CCDC26 long non-coding RNA glioma
CCEPR CCEPR CCHE1 cervical carcinoma expressed PCNA regulatory lncRNA cervical cancer
CDKN1A-AS1 CDKN1A-AS1 p21NAT CDKN1A antisense RNA 1 _
CDKN2B-AS1 NONHSAT130421,lnc-C9orf53-2:1 "ANRIL, p15AS, ENSG00000240498" CDKN2B antisense RNA 1 abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
CDR1-AS CDR1-AS "CDR1NAT, ciRS-7, CDR1as" CDR1 antisense RNA _
CDRT7 CDRT7 "NCRNA00025, LINC00025" CMT1A duplicated region transcript 7 (non-protein coding) _
CDRT8 CDRT8 N/A CMT1A duplicated region transcript 8 _
CECR3 CECR3 N/A "cat eye syndrome chromosome region, candidate 3 (non-protein coding)" cat eye syndrome
CECR5-AS1 CECR5-AS1 NCRNA00017 CECR5 antisense RNA 1 cat eye syndrome
CECR7 CECR7 SAHL1 "cat eye syndrome chromosome region, candidate 7 (non-protein coding)" cat eye syndrome
CECR9 CECR9 N/A "cat eye syndrome chromosome region, candidate 9 (non-protein coding)" cat eye syndrome
CEP83-AS1 CEP83-AS1 N/A CEP83 antisense RNA 1 (head to head) _
CIRBP-AS1 CIRBP-AS1 MGC39338 CIRBP antisense RNA 1 _
CISTR NONHSAT028496 "CISTR-ACT, CISTRACT, re52431" chondrogenesis-associated transcript _
CLRN1-AS1 CLRN1-AS1 UCRP CLRN1 antisense RNA 1 Usher syndrome type 3
COPG2IT1 COPG2IT1 "CIT1, NCRNA00170, COPG2AS" COPG2 imprinted transcript 1 (non-protein coding) _
CPS1-IT1 CPS1-IT1 "PRO0132, CPS1-IT" CPS1 intronic transcript 1 _
CRNDE Lnc-IRX3-4:2 "LOC643911, LINC00180, CRNDEP" colorectal neoplasia differentially expressed (non-protein coding) colorectal cancer
CSNK1G2-AS1 CSNK1G2-AS1 MGC39696 CSNK1G2 antisense RNA 1 _
CSTF3-AS1 CSTF3-AS1 N/A CSTF3 antisense RNA 1 (head to head) _
CTBP1-AS CTBP1-AS PCAT10 CTBP1 antisense RNA prostate cancer
CTBP1-AS2 CTBP1-AS2 MGC21675 CTBP1 antisense RNA 2 (head to head) _
CYP1B1-AS1 CYP1B1-AS1 MGC34824 CYP1B1 antisense RNA 1 _
CYP4A22-AS1 ENST00000444042.2 "Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506" CYP4A22 antisense RNA 1 _
CYP51A1-AS1 CYP51A1-AS1 "ENST00000453068, LRRD1-AS1" CYP51A1 antisense RNA 1 renal cell carcinoma
CYYR1-AS1 ENST00000357401.3 cysteine and tyrosine rich 1 antisense RNA 1 N/A _
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:C&oldid=1272158"